What is the treatment for a patient with a paracetamol (acetaminophen) overdose to protect the liver?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acetylcysteine for Liver Protection from Paracetamol Overdose

N-acetylcysteine (NAC) is the only proven antidote for paracetamol overdose and must be administered immediately to prevent hepatotoxicity, ideally within 8 hours of ingestion when it provides near-complete protection against liver damage. 1, 2

Immediate Treatment Protocol

Start NAC without delay in any patient with suspected or confirmed paracetamol overdose when:

  • Serum paracetamol level plots above the "possible toxicity" line on the Rumack-Matthew nomogram (drawn 4-24 hours post-ingestion) 1, 2
  • Time of ingestion is unknown but paracetamol is detectable 1
  • Hepatotoxicity is already present (elevated transaminases) 1
  • Acute liver failure with suspected paracetamol involvement, even without confirmatory history 1, 3

Do not wait for laboratory confirmation to start NAC if there is strong clinical suspicion. 3, 2

Timing Is Critical

The efficacy of NAC is directly tied to how quickly treatment begins:

  • Within 8 hours: Only 2.9% develop severe hepatotoxicity—near-complete protection 1, 4
  • Within 10 hours: 6.1% develop severe hepatotoxicity 1
  • 10-24 hours: 26.4% develop severe hepatotoxicity 1
  • After 24 hours: Still beneficial and must be given, though efficacy is significantly reduced 1, 3, 5

In the landmark study by Prescott et al., only 1 of 62 patients treated within 10 hours developed severe liver damage, compared to 33 of 57 (58%) who received supportive care alone. 4

NAC Dosing Regimens

Intravenous Protocol (21-hour regimen):

  • Loading dose: 150 mg/kg in 5% dextrose over 15 minutes 1, 3
  • Second dose: 50 mg/kg over 4 hours 1, 3
  • Third dose: 100 mg/kg over 16 hours 1, 3

Oral Protocol (72-hour regimen):

  • Loading dose: 140 mg/kg by mouth or nasogastric tube 1, 3
  • Maintenance: 70 mg/kg every 4 hours for 17 additional doses 1, 3

Both routes are equally effective, though IV may be preferred for vomiting patients or those with established hepatotoxicity. 1

Activated Charcoal Consideration

Give activated charcoal (1 g/kg) just prior to starting NAC if the patient presents within 4 hours of ingestion. 1, 3 Do not delay NAC administration even if charcoal has been given. 3

Special Clinical Scenarios Requiring NAC

Established Hepatic Failure

Administer NAC immediately regardless of time since ingestion in any patient with acute liver failure from paracetamol. 1, 3 NAC reduces mortality from 80% to 52%, cerebral edema from 68% to 40%, and need for inotropic support from 80% to 48%. 1

High-Risk Populations

Treat with NAC even if paracetamol levels are in the "non-toxic" range for:

  • Chronic alcohol users: Severe hepatotoxicity can occur with doses as low as 4-5 g/day 1
  • Fasting patients 3
  • Patients on enzyme-inducing drugs 1

Repeated Supratherapeutic Ingestions

Start NAC if:

  • Serum paracetamol ≥10 mg/mL, OR 1
  • AST or ALT >50 IU/L 1

Extended-Release Formulations

Serial paracetamol levels should be obtained as late increases may occur at 14 hours or beyond. 1, 3 Standard NAC dosing applies but monitoring may need extension. 3

When to Continue or Extend NAC Beyond Standard Protocol

Continue NAC beyond the standard 21-hour IV or 72-hour oral protocol in these situations:

  • Delayed presentation (>24 hours post-ingestion) 1, 3
  • Extended-release paracetamol 1, 3
  • Repeated supratherapeutic ingestions 1, 3
  • Unknown time of ingestion with detectable levels 1, 3
  • Any elevation in AST or ALT above normal 1
  • Rising transaminases 1
  • Any coagulopathy 1

When NAC Can Be Stopped

NAC may be discontinued when all of the following criteria are met:

  • Paracetamol level is undetectable 1
  • Liver function tests remain completely normal 1
  • No coagulopathy 1
  • Patient is not in a high-risk category 1

Critical Pitfalls to Avoid

The Rumack-Matthew nomogram does NOT apply to:

  • Presentations >24 hours after ingestion 1
  • Repeated supratherapeutic ingestions 1
  • Extended-release formulations 1

In these cases, base treatment decisions on paracetamol levels, liver function tests, and clinical presentation rather than nomogram placement. 1

Low or absent paracetamol levels do NOT rule out paracetamol poisoning if ingestion was remote or occurred over several days. 1 Very high aminotransferases (AST/ALT >3,500 IU/L) are highly correlated with paracetamol poisoning and should prompt NAC treatment even without confirmatory history. 1, 3

ICU-Level Care and Transplant Consultation

Contact a liver transplant center immediately for any patient with:

  • Severe hepatotoxicity (AST >1,000 IU/L) 1
  • Any coagulopathy 1
  • Evidence of acute liver failure 1

These patients require ICU-level supportive care with monitoring for encephalopathy, renal failure, and metabolic derangements. 1

Adverse Effects

Monitor for NAC-related adverse effects including:

  • Anaphylactic reactions (most common with IV route) 6, 7
  • Cutaneous reactions (IV route) 6
  • Nausea, vomiting, diarrhea (oral route) 6, 7
  • Transient bronchospasm (1-2%) 6

These adverse effects should not prevent NAC administration, as the benefits far outweigh the risks. 6

References

Guideline

Acetaminophen Overdose Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

N-Acetylcysteine Administration in Acetaminophen Overdose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Safety of late acetylcysteine treatment in paracetamol poisoning.

Human & experimental toxicology, 1990

Guideline

N-Acetylcysteine Treatment for Drug-Induced Hepatic Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.